13.45
-0.22 (-1.61%)
-0.22 (-1.61%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Pro
Monthly Subscription
for only
|
|
DDE w/Realtime (Monthly)
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Humanigen Inc | HGEN | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| -0.22 | -1.61% | 13.45 | 19:57:31 |
| Close Price | Low Price | High Price | Open Price | Previous Close |
|---|---|---|---|---|
| 12.955 | 12.88 | 13.4199 | 13.13 | 13.67 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 12.95 | 13.35 | 0.40 | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 3,091 | 380,373 | $ 13.07 | $ 4,970,685 | 768,072 | 9.00 - 16.00 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:55:00 | formt | 119 | $ 13.45 | USD |
Humanigen Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 691.17M | 51.39M | 19.06M | $ - | $ - | -0.45 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Humanigen News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical HGEN Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 14.03 | 15.6999 | 12.7514 | 14.04 | 662,113 | -0.58 | -4.13% |
| 1 Month | 9.56 | 16.00 | 9.50 | 12.99 | 843,744 | 3.89 | 40.69% |
| 3 Months | 10.85 | 16.00 | 9.00 | 12.56 | 838,844 | 2.60 | 23.96% |
| 6 Months | 10.85 | 16.00 | 9.00 | 12.56 | 838,844 | 2.60 | 23.96% |
| 1 Year | 10.85 | 16.00 | 9.00 | 12.56 | 838,844 | 2.60 | 23.96% |
| 3 Years | 10.85 | 16.00 | 9.00 | 12.56 | 838,844 | 2.60 | 23.96% |
| 5 Years | 10.85 | 16.00 | 9.00 | 12.56 | 838,844 | 2.60 | 23.96% |
Humanigen Description
| Humanigen Inc is a biopharmaceutical company engaged in the development of proprietary monoclonal antibodies for various oncology indications and to enhance T-cell therapies, making these treatments safer and cost-effective. It focuses on preventing the serious and potentially life-threatening side-effects associated with chimeric antigen receptor T-cell (CAR-T) therapy. Its pipeline includes programs such as Lenzilumab, Ifabotuzumab, and HGen005. |
